US FDA flags Dabur's Silvassa plant under Import Alert 66-40; company calls impact insignificant
Dabur India says only a small section of its Silvassa facility is affected by the US FDA's Import Alert 66-40, with domestic products and broader operations unaffected. Management has framed the financial impact as insignificant, but the alert puts a regulatory spotlight on the FMCG major's export-facing manufacturing footprint.
US FDA issued Import Alert 66-40 on Dabur's Silvassa unit; company says impact is insignificant as only a small part of plant is affected, domestic products unaffected. Tata Capital allotted Rs 2,030 crore NCDs; SP Apparels signed £4M UK subsidiary loan.